Apogem Capital’s HCA Healthcare HCA Stock Holding History

Apogem Capital’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,664	Closed	-$603K	–	192
2020 Q4	$603K	Buy	+3,664	New	+$536K	0.4%	82

Other funds holding HCA

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Apogem Capital's HCA Position: Q1 2021 in Review

Apogem Capital sold out of HCA Healthcare (HCA) in Q1 2021, closing a stake of 3,664 shares — an estimated $603K sold.

Apogem Capital first reported a position in HCA in Q4 2020 and held it in 1 quarter. The position peaked at $603K in Q4 2020. 786 funds tracked by Wall St. Rank hold HCA as of Q1 2021.

Apogem Capital reported no remaining HCA Healthcare position as of Q1 2021 after selling out during the quarter.
Apogem Capital sold 3,664 HCA Healthcare shares in Q1 2021, an estimated $603K.
Apogem Capital first reported a position in HCA Healthcare in Q4 2020 and held it in 1 quarter.
Apogem Capital's HCA Healthcare position peaked at $603K in Q4 2020.
786 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2021.

Based on Apogem Capital's 13F filing for Q1 2021, filed 14 May 2021.